Cartesian Therapeutics
RNAC
RNAC
92 hedge funds and large institutions have $79.7M invested in Cartesian Therapeutics in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 26 increasing their positions, 34 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
10% less funds holding
Funds holding: 102 → 92 (-10)
24% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 34
30% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 27
Holders
92
Holding in Top 10
1
Calls
$341K
Puts
$166K
Top Buyers
| 1 | +$9.51M | |
| 2 | +$4.58M | |
| 3 | +$1.52M | |
| 4 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$1.33M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.19M |
Top Sellers
| 1 | -$5.75M | |
| 2 | -$3.02M | |
| 3 | -$1.84M | |
| 4 |
Two Sigma Investments
New York
|
-$1.31M |
| 5 |
Renaissance Technologies
New York
|
-$1.18M |